AInvest★★★★★3-DAY FREE
Catch pre-market movers with AI signals.
Claim Trial
--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About EBS20260918P5
Biotechnology Ⅲ
Emergent Biosolutions Inc., founded in May 1998 in Michigan, USA, was changed to Delaware Corporation in June 2004. The company has two operating divisions: Biodefense and Bioscience. The company is a global life sciences company focused on providing innovative preparedness and response solutions to unexpected, intentional and naturally occurring public health threats.
